"Esophagectomy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Excision of part (partial) or all (total) of the esophagus. (Dorland, 28th ed)
| Descriptor ID |
D016629
|
| MeSH Number(s) |
E04.210.346
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Esophagectomy".
Below are MeSH descriptors whose meaning is more specific than "Esophagectomy".
This graph shows the total number of publications written about "Esophagectomy" by people in this website by year, and whether "Esophagectomy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 3 | 1 | 4 |
| 2014 | 5 | 0 | 5 |
| 2015 | 3 | 0 | 3 |
| 2016 | 2 | 1 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 1 | 3 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Esophagectomy" by people in Profiles.
-
de Geus SWL, Hirji S, Hachey KJ, Sachs TE, Suzuki K, Ng SC, Swanson S, Litle VR, D'Amico T, Tseng JF. Lymphadenectomy and Survival After Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma: Is More Better? J Gastrointest Surg. 2020 11; 24(11):2447-2455.
-
Lu M, Luketich JD, Levy RM, Awais O, Sarkaria I, Visintainer P, Nason KS. Anastomotic complications after esophagectomy: Influence of omentoplasty in propensity-weighted cohorts. J Thorac Cardiovasc Surg. 2020 05; 159(5):2096-2105.
-
Lowenthal BM, Nason KS, Pennathur A, Luketich JD, Pai RK, Davison JM, Ma C. Loss of ARID1A expression is associated with DNA mismatch repair protein deficiency and favorable prognosis in advanced stage surgically resected esophageal adenocarcinoma. Hum Pathol. 2019 12; 94:1-10.
-
Tseng J, Posner MC. For Gastroesophageal Junction Cancers, Does an "Esophageal" or "Gastric" Surgical Approach Offer Better Perioperative and Oncologic Outcomes? Ann Surg Oncol. 2020 Feb; 27(2):511-517.
-
Sterbling HM, Rosen AK, Hachey KJ, Vellanki NS, Hewes PD, Rao SR, Pinjic E, Fernando HC, Litle VR. Caprini Risk Model Decreases Venous Thromboembolism Rates in Thoracic Surgery Cancer Patients. Ann Thorac Surg. 2018 03; 105(3):879-885.
-
Tam V, Luketich JD, Winger DG, Sarkaria IS, Levy RM, Christie NA, Awais O, Shende MR, Nason KS. Cancer Recurrence After Esophagectomy: Impact of Postoperative Infection in Propensity-Matched Cohorts. Ann Thorac Surg. 2016 Nov; 102(5):1638-1646.
-
Huerter ME, Charles EJ, Downs EA, Hu Y, Lau CL, Isbell JM, McMurry TL, Kozower BD. Enteral Access is not Required for Esophageal Cancer Patients Undergoing Neoadjuvant Therapy. Ann Thorac Surg. 2016 Sep; 102(3):948-954.
-
Nason KS. Improving Quality: When Surgeons Take the Bit Between the Teeth, Patients Win! Semin Thorac Cardiovasc Surg. 2016; 28(1):170-1.
-
Nason KS. Minimal or maximal surgery for esophageal cancer? J Thorac Cardiovasc Surg. 2016 Mar; 151(3):633-635.
-
Pennathur A, Gooding WE, Nason KS, Luketich JD. Reply to Letter: "Poorer Survival for Stage IIa Patients After Minimally Invasive Esophagectomy". Ann Surg. 2015 Aug; 262(2):e45-7.